Search

everythinglearnresearchcommunity

for

Search:↓

Transgender women can develop feminine traits and improve their quality of life through hormone therapy and surgery, but results vary and access to surgery can be limited.

Transgender youth on hormone therapy need personalized acne treatments and supportive care.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document advises health care providers on how to support transgender and gender-diverse youth with appropriate care and referrals.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Bicalutamide may help treat female pattern hair loss.

Social rejection can harm long-term mental health in transgender individuals.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The US Military supports transgender health care, but many needed skin procedures aren't covered by insurance.

Topical minoxidil helps transgender individuals assigned female at birth grow more facial hair.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The healthcare for transgender veterans could be better with a more unified team approach.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.